Carcinogénesis Hormonal

Publicaciones

  • 01/07/2024

    The Journal of steroid biochemistry and molecular biology

    Antiprogestins for breast cancer treatment: we are almost ready

    Andrés Elia, Gabriela Pataccini, Leo Saldain, Luisa Ambrosio, Claudia Lanari, Paola Rojas

  • 13/12/2023

    Endocrine-related cancer

    Steroid profile in patients with breast cancer and in mice treated with mifepristone

    Andres Elía, Leo Saldain, Silvia Lovisi, Paula Martínez Vazquez, Javier Burruchaga, Caroline A Lamb, Isabel Alicia Lüthy, Federico Diez, Natalie Z M Homer, Ruth Andrew, Paola Rojas, Claudia Lanari

  • 27/07/2023

    Journal of proteome research

    Tumor Lipid Signatures Are Descriptive of Acquisition of Therapy Resistance in an Endocrine-Related Breast Cancer Mouse Model

    Rita Araújo, Victoria Fabris, Caroline A Lamb, Andrés Elía, Claudia Lanari, Luisa A Helguero, Ana M Gil

  • 13/04/2023

    Frontiers in endocrinology

    Editorial: Steroid hormone receptors and cell cycle in breast cancer

    Victoria T Fabris, Laura Spring, Luisa A Helguero

  • 13/04/2023

    Frontiers in endocrinology

    Editorial: Steroid hormone receptors and cell cycle in breast cancer

    Victoria T Fabris, Laura Spring, Luisa A Helguero

  • 01/03/2023

    Clinical Cancer Research

    Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial

    Andrés Elía, Leo Saldain, Silvia I Vanzulli, Luisa A Helguero, Caroline A Lamb, Victoria Fabris, Gabriela Pataccini, Paula Martínez-Vazquez, Javier Burruchaga, Ines Caillet-Bois, Eunice Spengler, Gabriela Acosta Haab, Marcos Liguori, Alejandra Castets, Silvia Lovisi, María F Abascal, Virginia Novaro, Jana Sánchez, Javier Muñoz, Jose M Belizán, Martín C Abba, Hugo Gass, Paola Rojas, Claudia Lanari

  • Journal of cellular biochemistry

    01/05/2022

    International Journal of Cancer

    Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1

    María Florencia Abascal, Andrés Elia, Michelle Alvarez, Gabriela Pataccini, Gonzalo Sequeira, Marina Riggio, Virginia Figueroa, Caroline A Lamb, Paola A Rojas, Eunice Spengler, Paula Martínez-Vazquez, Javier Burruchaga, Marcos Liguori, Ana Sahores, Victoria Wargon, Alfredo Molinolo, Stephen Hewitt, Marc Lombes, Carol Sartorius, Silvia Inés Vanzulli, Sebastián Giulianelli, Claudia Lanari

  • Frontiers in Oncology

    01/03/2022

    Frontiers in Oncology

    Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy

    Rita Araújo, Victoria Fabris, Caroline A Lamb, Claudia Lanari, Luisa A Helguero, Ana M Gil

  • 01/02/2022

    Endocrinology

    New insights in the interaction of FGF/FGFR and steroid receptor signaling in breast cancer

    Cecilia Pérez Piñero, Sebastián Giulianelli, Caroline A Lamb, Claudia Lanari

  • 24/01/2022

    Cell Death and Disease

    Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression

    Pablo Carabias, María V Espelt, María L Bacigalupo, Paola Rojas, Luciana Sarrias, Ayelén Rubin, Nicolás A Saffioti, María T Elola, Juan P Rossi, Carlota Wolfenstein-Todel, Gabriel A Rabinovich, María F Troncoso